Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stages

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Moneriz, Carlos ^a,d   Marín García, Patricia ^a,b   García Granados, Andrés ^c   Bautista, José M ^a   Diez, Amalia ^a   Puyet, Antonio ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSIDAD DE CARTAGENA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CHLOROQUINE; MASLINIC ACID; ANTIMALARIAL AGENT; TRITERPENE;

ANTIMALARIAL ACTIVITY; ARTICLE; DOSE RESPONSE; ERYTHROCYTE; IC 50; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; SCHIZONT; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MALARIA FALCIPARUM; PARASITEMIA; PARASITOLOGY;

ANTIMALARIALS; ATOVAQUONE; CHLOROQUINE; ERYTHROCYTES; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; TRITERPENES;

EID: 79953751628     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-82     Document Type: Article

References (48)

1. Drug discovery for malaria: a very challenging and timely endeavor. MH Gelb, Curr Top Med Chem 2007 11 440 445 (Pubitemid 47302852)
2. New antimalarial drugs. J Wiesner R Ortmann H Jomaa M Schlitzer, Angew Chem Int Ed 2003 42 5274 5293 10.1002/anie.200200569 (Pubitemid 37462636)
3. The global portfolio of new antimalarial medicines under development. P Olliaro TNC Wells, Clin Pharmacol Ther 2009 85 584 595 10.1038/clpt.2009.51 19404247
4. Plasmodial heat shock proteins: targets for chemotherapy. A Shonhai, FEMS Immunol Med Microbiol 2010 58 61 74 10.1111/j.1574-695X.2009.00639.x 20041948
5. Proteases of Plasmodium falciparum as potential drug targets and inhibitors thereof. C Wegscheid-Gerlach HD Gerber WE Diederich, Curr Top Med Chem 2010 10 346 367 10.2174/156802610790725461 20166950
6. Antimalarial drugs - What is in use and what is in the pipeline. M Schlitzer, Arch Pharm 2008 341 149 163 10.1002/ardp.200700184
7. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum. A Radfar A Diez JM Bautista, Free Radical Bio Med 2008 44 2034 2042 10.1016/j.freeradbiomed.2008. 03.010
8. History, dynamics, and public health importance of malaria parasite resistance. AO Talisuna P Bloland U D'Alessandro, Clin Microbiol Rev 2004 17 235 + 10.1128/CMR.17.1.235-254.2004 14726463
9. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. WO Rogers R Sem T Tero P Chim P Lim S Muth D Socheat F Ariey C Wongsrichanalai, Malar J 2009 8 19134197
10. Artemisinin-resistant malaria in Asia. H Noedl D Socheat W Satimai, N Engl J Med 2009 361 540 541 10.1056/NEJMc0900231 19641219
11. Antimalarial compounds isolated from plants used in traditional medicine. J Bero M Frederich J Quetin-Leclercq, J Pharm Pharmacol 2009 61 1401 1433 10.1211/jpp.61.11.0001 19903367
12. Process for the industrial recovery of oleanoic and maslinic acids contained in the olive milling subproducts. A García-Granados A Martínez A Parra F rivas, Univ Granada 1998
13. Maslinic acid, a natural compound from olives, induces apoptosis in HT-29 human colon cancer cell line. ME Juan U Wenzel V Ruiz-Gutierrez JM Planas H Daniel, FASEB J 2005 19 996 A996
14. (2 alpha,3 beta)-2,3-dihydroxyolean-12-en-28-oic acid, a new natural triterpene from Olea europea, induces caspase dependent apoptosis selectively in colon adenocarcinoma cells. FJ Reyes JJ Centelles JA Lupianez M Cascante, FEBS Lett 2006 580 6302 6310 10.1016/j.febslet.2006.10.038 17083937 (Pubitemid 44794373)
15. Supressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages. AM Martin RDP Vazquez A Fernandez-Arche V Ruiz-Gutierrez, Free Rad Res 2006 40 295 302 10.1080/10715760500467935 (Pubitemid 43245445)
16. Antioxidant activity of maslinic acid, a triterpene derivative obtained from Olea europaea. MP Montilla A Agil MC Navarro MI Jimenez A Garcia-Granados A Parra MM Cabo, Planta Med 2003 69 472 474 10.1055/s-2003-39698 12802735 (Pubitemid 36774194)
17. Anti-HIV triterpene acids from Geum japonicum. HX Xu FQ Zeng M Wan KY Sim, J Nat Prod 1996 59 643 645 10.1021/np960165e 8759159 (Pubitemid 26264625)
18. Antimicrobial triterpenoids from Licania heteromorpha. A Braca I Morelli J Mendez L Battinelli L Braghiroli G Mazzanti, Planta Med 2000 66 768 769 10.1055/s-2000-9601 11199141 (Pubitemid 32038939)
19. Triterpenic compounds from "orujo" olive oil elicit vasorelaxation in aorta from spontaneously hypertensive rats. R Rodriguez-Rodriguez JS Perona MD Herrera V Ruiz-Gutierrez, J Agr Food Chem 2006 54 2096 2102 10.1021/jf0528512
20. Maslinic acid reduces blood glucose in KK-A(y) mice. J Liu H Sun W Duan D Mu L Zhang, Biol Pharm Bull 2007 30 2075 2078 10.1248/bpb.30.2075 17978478 (Pubitemid 350097042)
21. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: Synthesis, structure-activity relationships, and X-ray crystallographic studies. XA Wen HB Sun J Liu KG Cheng P Zhang LY Zhang J Hao LY Zhang PZ Ni SE Zographos DD Leonidas KM Alexacou T Gimisis JM Hayes NG Oikonomakos, J Med Chem 2008 51 3540 3554 10.1021/jm8000949 18517260 (Pubitemid 351875009)
22. Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. W-W Qiu Q Shen F Yang B Wang H Zou J-Y Li J Li J Tang, Bioorg Med Chem Lett 2009 19 6618 6622 10.1016/j.bmcl.2009.10.017 19846303
23. Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells. ME Juan JM Planas V Ruiz-Gutierrez H Daniel U Wenzel, Brit J Nutr 2008 100 36 43 10.1017/S0007114508882979 18298868
24. Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii. LM De Pablos G Gonzalez R Rodrigues AG Granados A Parra A Osuna, J Nat Prod 2010 73 831 834 10.1021/np900749b 20441162
25. HIV protease inhibitors inhibit the development of preerythrocytic-stage Plasmodium parasites. CV Hobbs T Voza A Coppi B Kirmse K Marsh W Borkowsky P Sinnis, J Infect Dis 2009 199 134 141 10.1086/594369 19032102
26. Use of maslinic acid as an antiparasitic agent against phylum apicomplexa protozoans. In WIPO (ed. (Spanish), U. d. G.), Patent No: WO/2007/034009. A García-Granados, 2007
27. New antimalarials with a triterpenic scaffold from Momordica balsamina. C Ramalhete D Lopes S Mulhovo J Molnar VE Rosario MJU Ferreira, Bioorganic & Medicinal Chemistry 2010 18 5254 5260
28. Trypanocidal activity and acute toxicity assessment of triterpene acids. DD Ferreira VR Esperandim MPA Toldo J Saraiva WR Cunha S de Albuquerque, Parasitol Res 2010 106 985 989 10.1007/s00436-010-1740-2 20140451
29. Antiplasmodial triterpenes from twigs of Gardenia saxatilis. A Suksamrarn T Tanachatchairatana S Kanokmedhakul, J Ethnopharmacol 2003 88 275 277 10.1016/S0378-8741(03)00261-7 12963155 (Pubitemid 37083457)
30. Inhibitory effect of ursolic acid derivatives on hydrogen peroxide- and glutathione-mediated degradation of hemin: A possible additional mechanism of action for antimalarial activity. C Mullié A Jonet A Dassonville-Klimpt G Gosmann P Sonnet, Exp Parasitol 2010 125 202 207 20109452
31. Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors. XA Wen P Zhang J Liu LY Zhang XM Wu PZ Ni HB Sun, Bioorg Med chem Lett 2006 16 722 726 10.1016/j.bmcl.2005.10.014 16246555 (Pubitemid 43014868)
32. Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides. A Parra F Rivas PE Lopez A Garcia-Granados A Martinez F Albericio N Marquez E Munoz, Bioorg Med Chem 2009 17 1139 1145 10.1016/j.bmc.2008.12.041 19135380
33. Malaria Research and Reference Reagent Resorce Center (MR4). http://www.mr4.org
34. Investigation of a novel approach to scoring Giemsa-stained malaria-infected thin blood films. O Proudfoot N Drew A Scholzen S Xiang M Plebanski, Malar J 2008 7 62 18426594
35. Synchronous culture of Plasmodium falciparum at high parasitemia levels. A Radfar D Méndez C Moneriz M Linares P Marín-García A Puyet A Diez JM Bautista, Nat Protoc 2009 4 1828 1844 10.1038/nprot.2009.198 20010937
36. Haemoglobin interference and increased sensitivity of fluorimetric assays for quantification of low-parasitaemia Plasmodium infected erythrocytes. C Moneriz P Marin-Garcia JM Bautista A Diez A Puyet, Malar J 2009 8 279 10.1186/1475-2875-8-279 19961586
37. A non-radiolabelled ferriprotoporphyrin IX biomineralisation inhibition test for the high throughput screening of antimalarial compounds. E Deharo RN Garcia P Oporto A Gimenez M Sauvain V Jullian H Ginsburg, Exp Parasitol 2002 100 252 256 10.1016/S0014-4894(02)00027-9 12128052 (Pubitemid 36279295)
38. Antimalarial Exposure Delays Plasmodium falciparum Intra-Erythrocytic Cycle and Drives Drug Transporter Genes Expression. MI Veiga PE Ferreira BA Schmidt U Ribacke A Bjorkman A Tichopad JP Gil, Plos One 2010 5
39. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. M Korsinczky NH Chen B Kotecka A Saul K Rieckmann Q Cheng, Antimicrob Agents Chemoter 2000 44 2100 2108 10.1128/AAC.44.8.2100-2108.2000 (Pubitemid 30484433)
40. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. DA Fidock T Nomura AK Talley RA Cooper SM Dzekunov MT Ferdig LMB Ursos ABS Sidhu B Naude KW Deitsch XZ Su JC Wootton PD Roepe TE Wellems, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
41. Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray. Z Bozdech JC Zhu MP Joachimiak FE Cohen B Pulliam JL DeRisi, Genome Biol 2003 4
42. Triterpenes as potential dimerization inhibitors of HIV-1 protease. L Quéré R Wenger HJ Schramm, Biochem Biophys Res commun 1996 227 484 488 8967903 (Pubitemid 26362830)
43. Inhibition of DNA polymerases and DNA topoisomerase II by triterpenes produced by plant callus. Y Mizushina A Ikuta K Endoh M Oshige N Kasai K Kamiya T Satake H Takazawa H Morita H Tomiyasu H Yoshida F Sugawara K Sakaguchi, Biochem Biophys Res commun 2003 305 365 373 10.1016/S0006-291X(03)00765-4 12745084 (Pubitemid 36555478)
44. Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum. HR Goulart EA Kimura VJ Peres AS Couto FAA Duarte AM Katzin, Antimicrob Agents Chemoter 2004 48 2502 2509 10.1128/AAC.48.7.2502-2509.2004 (Pubitemid 38823417)
45. Antibiotics for prophylaxis of Plasmodium falciparum infections: In vitro activity of doxycycline against Senegalese isolates. B Pradines A Spiegel C Rogier A Tall J Mosnier T Fusai JF Trape D Parzy, Am J Trop Med Hyg 2000 62 82 85 10761729 (Pubitemid 30180355)
46. Multiple antibiotics exert delayed effects against the Plasmodium falciparum anicoplast. EL Dahl PJ Rosenthal, Antimicrobial Agents and Chemotherapy 2007 51 3485 3490 10.1128/AAC.00527-07 17698630 (Pubitemid 47519333)
47. Nuclear-encoded DnaJ homologue of Plasmodium falciparum interacts with replication ori of the apicoplast genome. A Kumar A Tanveer S Biswas E Ram A Gupta B Kumar S Habib, Mol Microbiol 2010 75 942 956 10.1111/j.1365-2958.2009. 07033.x 20487289
48. The apicoplast as an antimalarial drug target. SA Ralph MC D'Ombrain GI McFadden, Drug Resist Update 2001 4 145 151 10.1054/drup.2001.0205 (Pubitemid 33089452)